Association of Secukinumab Treatment With Tuberculosis Reactivation in Patients With Psoriasis, Psoriatic Arthritis, or Ankylosing Spondylitis

202074 citationsJournal Articlehybrid Open Access

Authors

Boni E. Elewski · University of Alabama at Birmingham Hospital

John W. Baddley · University of Alabama at Birmingham

Atul Deodhar · Oregon Health & Science University

Marina Magrey · MetroHealth Medical Center

Phoebe Rich · Oregon Dermatology & Research Center

Enrique R. Soriano · Hospital Italiano de Buenos Aires

Jennifer Soung

Abstract

This study found that LTBI reported as an AE after secukinumab treatment was uncommon and appeared to support the use of secukinumab in chronic systemic inflammatory conditions.

Topics & Keywords

Infectious Diseases and Tuberculosis Tuberculosis Research and Epidemiology Spondyloarthritis Studies and Treatments

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: JAMA Dermatology

Volume 157, Issue 1, pp. 43-43

DOI: 10.1001/jamadermatol.2020.3257

Field-Weighted Citation Impact: 8.37